Gary Bridger
CIK 1600049 · EVP, Research & Development · last filed 2026-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.9K
Companies
4
Total Filings
20
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Director | 4,722 | $4.00 | $18.9K | $0 | 10 | 2026-01-07 |
| Neurogene Inc. (AQXP) Delisted | Director | 0 | — | — | $0 | 7 | 2018-05-09 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | 0 | — | — | $0 | 2 | 2015-11-03 |
| XENE | EVP, Research & Development | — | $52.10 | — | $0 | 1 | 2014-11-25 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-09 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-10 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-11 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-03 | Neurogene Inc. (AQXP) Delisted | Other (J) | −1,543,989 | $0 | EDGAR |
| 2015-11-03 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Other (J) | −3,469,528 | $0 | EDGAR |
| 2015-05-21 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-16 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-25 | XENE | Grant (A) | — | $0 | EDGAR |
| 2014-03-14 | Neurogene Inc. (AQXP) Delisted | Mixed | +36,502 | $0 | EDGAR |
| 2014-03-10 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.